LG Energy Solution

Phase A — Understand the business

Lens 1 · Company Overview

LG Energy Solution (LGES) is the battery-cell arm spun out of LG Chem and IPO'd in January 2022 — at the time Korea's largest-ever IPO and, on debut, the country's second-most-valuable company behind Samsung Electronics. It makes lithium-ion cells, modules and packs across three end-markets:

1. Automotive (EV) batteries — the historical core. Pouch and, increasingly, cylindrical cells sold to Western and Korean OEMs. This is the segment in structural distress.
2. Energy Storage Systems (ESS) — grid-scale and utility/data-center storage, increasingly LFP chemistry. This is the designated growth engine and the entire bull case for 2026+.
3. Small/IT cells — consumer cylindrical and pouch (legacy, lower-growth).

Business model in plain terms: LGES is a capital-intensive contract manufacturer of an increasingly commoditized industrial input. It wins multi-year, multi-GWh supply agreements from automakers and utilities, then sinks billions of capex into dedicated capacity (often via JVs that co-locate with the customer) to fulfill them. Margins are thin and cyclical; the swing factors are (a) plant utilization, (b) metal/lithium cost pass-through lags, and (c) — critically since 2024 — U.S. government production subsidies.

Key customers (all ``): General Motors (via the Ultium Cells JV), Tesla (a $4.3B LFP prismatic deal for Megapack 3, Lansing MI, 2027-2030 ), Toyota (20GWh/yr of modules from 2025 ), Hyundai, Mercedes-Benz, Rivian, Honda, and — until December 2025 — Ford. The 46-series cylindrical order book also names BMW (~$6.7B), Chery and Aptera.

Contract structure & payment terms: Long-term off-take agreements, typically 5-7 years, frequently structured as co-investment JVs (Ultium with GM; planned/withdrawn JVs with others). These are NOT take-or-pay in the protective sense — the December 2025 cancellations prove the customer can walk when policy and demand shift, and LGES eats the stranded capacity. That is the single most important structural fact about this business: the contracted backlog is softer than the GWh headline implies. Concentration is meaningful — Ford alone was ~28.5% of FY-latest revenue before it cancelled.

Lens 2 · Supply Chain

Map: upstream raw materials → refined cathode/anode → LGES cell/module → OEM pack integration → end vehicle/grid. Named stakeholders along the chain (``, general industry knowledge):

• Raw lithium / nickel / cobalt: sourced via off-take with miners and traders. LGES has signed lithium off-takes over the years (e.g. with producers in Australia/Chile/North America) — specific live counterparties n/a at this granularity.
• Cathode (the value chokepoint): LGES is partly vertically captive through the LG family — LG Chem is a major cathode-active-material (CAM) supplier, which is a genuine structural advantage vs. peers who buy CAM merchant. Also POSCO Future M (Korean CAM/anode).
• Separator / electrolyte / foils: Korean and Japanese specialty suppliers (e.g. separator from SK IE Technology / Toray; electrolyte from Enchem and others).
• Cell/module manufacturing (LGES itself): plants in Korea (Ochang — now the 4695 cylindrical lead site ), Poland (Wrocław — the European hub), China (Nanjing), and a rapidly built North American footprint: Michigan (Holland + the Ultium Lansing/Ohio/Tennessee JV sites with GM), Arizona (Queen Creek — $5.5B LFP + 46-series complex, sample production mid-2026 ).
• Downstream integration: the OEM (GM, Tesla, Toyota…) takes cells/modules into its own pack and vehicle. For ESS, the buyer is utilities, IPPs, and increasingly data-center / hyperscaler demand.

Chokepoints & single-source dependencies:

• The AMPC subsidy is the real chokepoint — not a physical input but a policy input the entire P&L now hangs on (see Lens 5).
• Chinese refining dominance upstream: the West's structural problem is that China controls the midstream (refining, CAM, LFP precursor). LGES's non-China North American buildout is its hedge and its IRA-eligibility play.
• Customer concentration downstream is itself a chokepoint — losing one OEM program strands a purpose-built line.

This lens is honest about its limits: without supply-chain.md compiled, the named-supplier map is at the level of public knowledge, not a verified row-by-row BOM.

Lens 3 · Competitive Advantages (moats)

Where LGES genuinely has an edge:

• Scale + #3 global position — 108.8 GWh installed in 2025, 9.2% global share, the largest non-Chinese player. Manufacturing know-how at gigafactory scale is a real, hard-won capability.
• The Western/non-China franchise — for any OEM that needs IRA-compliant, non-Chinese cells, the realistic menu is LGES, Samsung SDI, SK On, and Panasonic. LGES is the deepest of these. This is a policy-conferred moat, which is exactly why it's fragile.
• Technology breadth — pouch + cylindrical (46-series/4680-4695) + LFP + a credible solid-state roadmap (polymer 2026, sulfide 2030 ). It is one of very few players executing across all major form factors.
• LG-family vertical integration into cathode (LG Chem) — a cost/security advantage merchant peers lack.

Where the moat is weak (be honest):

• The product is commoditizing. LFP — the chemistry winning the volume war — was perfected and is dominated by CATL and BYD, who together hold ~55-57% of the global market and are taking share (CATL 39.2% in 2025, 40.7% in Q1 2026; BYD 16.4%). The combined Korean trio (LGES + SK On + Samsung SDI) fell to ~16%, down 3.5pts YoY. LGES is losing the share war.
• Bargaining power is poor in both directions. Upstream, lithium/CAM pricing is set by the market. Downstream, the December cancellations show OEMs hold the whip hand — they can terminate on policy grounds and LGES absorbs the stranded plant. A moat that lets your single largest customer walk on 28.5% of revenue is not a strong moat.
• Switching costs are real but eroding — qualifying a new cell supplier into an EV platform takes years, which protected incumbents. But as chemistry standardizes on LFP and Chinese players localize (or license, e.g. CATL-Ford LRS), that lock-in weakens.

Net: the moat is scale + Western-eligibility, not technology + pricing power. It is a defensible #3, not a franchise that controls its own economics.

Lens 4 · Segments

Hard constraint: segments.csv is an empty stub — there are **no segment numbers**. The company does not break out clean USD segment revenue/EBIT in the English press releases sourced here. So this lens is directional, not a sourced segment table.

• Automotive (EV): still the majority of revenue but decelerating/declining — total FY2025 revenue fell to KRW 23.7T from KRW 25.6T in 2024 (−7.6% YoY), explicitly attributed to "the slowdown in major customers' EV sales". North America was the soft spot (subsidy rollback, tariffs, demand cooling).
• ESS: the accelerating segment. LGES "saw solid growth in ESS sales as it proactively expanded its LFP production capacity in North America". It secured ~140 GWh of ESS order backlog in North America alone, driven by grid-scale, data-center and utility demand. The North American ESS network targets >50 GWh production capacity by end-2026.
• Geography: the strategic tension is North America (high subsidy, now-weakening EV demand, strong ESS pull) vs. Europe (Poland hub, also soft EV) vs. Korea/China (home + export). The capital is being redirected toward North American ESS and away from speculative EV capacity (Arizona ESS plant paused; Michigan absorbs ESS instead ).

Trend & cause: the whole company is mid-pivot from a declining auto-cell business to a growing grid-storage business. The 2025 revenue decline + 2026 swing-to-loss is the cost of that transition colliding with the EV demand air-pocket. Whether ESS can be big enough, fast enough, at a real margin is the entire investment question.

---

Phase B — Measure performance

Lens 5 · Earnings Result

FY2025 (reported 2026-01-28):

• Revenue: KRW 23.7T (−7.6% YoY, from ~KRW 25.6T).
• Operating profit: KRW 1.3T (+133.9% YoY), 5.7% OP margin — including the North American production incentive (AMPC).
• The YoY OP jump is flattered by AMPC scaling up and a weak 2024 base; the underlying EV-cell business deteriorated.

Q1 2026 (reported ~2026-04-30):

• Revenue: KRW 6.6T (+1.2% QoQ) — the fifth consecutive quarter of sequential revenue growth, driven by ESS.
• Operating result: a LOSS of KRW −207.8B (≈ −$150M).
• AMPC included in the quarter: KRW 189.8B. Critically, AMPC is now booked in revenue starting 2026.
• Ex-AMPC operating loss: KRW −397.5B. This is the number that matters: stripped of the U.S. subsidy, the core business lost ~KRW 400B in a single quarter. AMPC isn't a kicker on top of profit — it is the only thing standing between LGES and a deep operating loss.

Margin moves: gross/operating margin compressed on low EV-plant utilization and the cost of ramping new ESS/cylindrical lines. Specific gross-margin figure n/a.

Balance sheet flags: TTM EPS is negative — Yahoo shows TTM EPS ≈ −KRW 6,851 / ≈ −$4.80; P/B ~5.5x, P/S ~4.7x; no meaningful P/E (negative earnings). Net debt has risen through the capex supercycle; precise net-debt figure n/a from these results.

Guidance/outlook: management guided to 40% YoY capex reduction, "execute capex only for essential investments," ESS as the demand driver, and >50 GWh NA ESS capacity by year-end. Tone has shifted from "build everywhere" (2022-2024) to "preserve cash, pivot to ESS, manage EV risk."

Market reaction: the stock has been weak through the cancellation news and the swing to loss; LGES fell ~8% on a session in late 2025 on subsidy/H2 concerns. Shares ~KRW 384,500 (2026-06-11), versus the KRW 597,000 IPO-day open in Jan 2022.

Unusual vs. its own history: the swing from a (subsidy-aided) full-year profit to a Q1 operating loss, plus two customer cancellations totaling ~$9.2B in contracted value within weeks, is a clear negative regime change.

Lens 6 · Earnings Calls (sentiment trend)

transcripts/ is empty — no call data. Directional read from web coverage of the last ~4 prints:

• Q2 2025: "strong revenue beat, stock drops" — the market looked through the beat to the H2 warning on subsidies/demand. Management began explicitly flagging tariff + subsidy-expiry risk (federal EV credit ending Sept 30).
• Q3 2025: "strong results on AMPC credits" — the narrative crystallized that the headline profit is an AMPC story.
• Q4/FY2025 (Jan 2026): explicit EV/ESS divergence; capex discipline; ESS pivot.
• Q1 2026 + 2026 Partners Day: CEO Kim Dong-myung frames the market as entering a "value shift" phase — demand "expanding beyond EVs into ESS" — and pitches turning "the current industry slowdown into an opportunity" via product diversity (ESS) and profitability/risk management in EV.

Tone shift over time: from confident hyper-growth capacity guidance (2022-23) → cautious hedging on H2 2025 → damage-control + pivot framing in 2026. The phrases they've added: "value shift," "ESS-led," "capex discipline," "essential investments only." The phrase they've effectively stopped leaning on: aggressive multi-year EV volume/share targets. That is the sentiment tell — management is repositioning expectations away from the EV super-cycle they sold at IPO.

Lens 7 · Comps

Peer set: the global cell makers.

Read: CATL trades at ~22.6x with ~40% share, growing, and actual profits — the quality compounder of the group. LGES has no clean P/E (losses ex-AMPC) and trades on P/B (~5.5x) and P/S (~4.7x) — i.e., the market is valuing it on future capacity and the eventual ESS earnings, not current cash flow. The Korean trio (LGES, Samsung SDI, SK On) are all earnings-impaired right now; the Chinese duo are taking the profits. On fundamentals today, LGES is the more expensive, lower-growth, lower-margin asset versus CATL — you are paying a Western-eligibility premium and an ESS-optionality premium, not paying for present economics. Most peer cells above are n/a rather than guessed; treat the table as incomplete by design.

Lens 8 · Stock-Price Catalysts (>5% moves, last ~5 years)

What actually moves this name ``:

• IPO debut, Jan 27 2022 — opened KRW 597,000 (+~99% over the KRW 300,000 IPO price), $98.3B market cap, #2 in Korea. The high-water mark of EV-mania valuation.
• 2021 GM Chevy Bolt recall — 13 confirmed battery fires; LG (LGES + LG Electronics) agreed to pay GM up to $1.9B; it forced LGES to suspend its IPO process before relaunching. NHTSA opened an investigation in 2022. Quality/recall risk is a recurring share catalyst for cell makers.
• 2022-2024 de-rating — from the ~KRW 600K IPO peak down toward the mid-300s as EV growth slowed and the IRA capex bill mounted.
• 2025: subsidy-cliff fear — the stock fell ~8% in a session on H2-2025 concerns about the Sept 30 federal EV-credit expiry and tariffs; repeatedly sold off on AMPC/IRA-policy headlines even when revenue beat.
• Dec 2025: the cancellations — Ford terminates the $6.5B / KRW 9.6T deal (Dec 17) and Freudenberg/FBPS the $2.7B / KRW 3.9T deal (Dec 26). The clearest negative fundamental catalyst in the company's history — ~28.5% of revenue of contracted future volume erased.
• Q1 2026: swing to operating loss — confirmed the core business is underwater ex-subsidy.

Pattern: this stock trades on (1) U.S. policy (IRA/AMPC/EV credits), (2) major-customer order news, and (3) recall/quality events far more than on quarter-to-quarter opex. The market prices LGES as a levered bet on Western EV/ESS policy and demand — which is exactly why AMPC repeal risk dominates the thesis.

---

Phase C — Judge people & books

Lens 9 · Management

• CEO: Kim Dong-myung, President & CEO, term March 2024 → March 2027. A long-time LG battery/operations executive (career insider, not an outside hire). Archetype: professional manager / operator, not founder. For a capital-intensive incumbent mid-pivot, that's arguably the right profile — execution and capital discipline over visionary risk-taking.
• Track record: under his watch LGES executed the North American buildout and is now executing the retrenchment (40% capex cut, ESS redirect). Hard to quantify "value created" given the stock is down and the company swung to a loss — but much of that is sector beta (the whole EV-cell complex de-rated), not idiosyncratic mismanagement.
• Skin in the game / insider ownership: LGES is ~81.8% owned by parent LG Chem (insider-transactions.csv empty — figure is general public knowledge ``, verify before relying). This is the governance crux: minority public holders are along for the ride on LG-group strategy. Personal CEO ownership is immaterial (typical for a Korean chaebol professional exec).
• Capital-allocation history: the defining call was the aggressive 2022-2024 IRA-driven capacity build, financed with rising debt — which now looks over-built into a demand air-pocket, leaving stranded/paused plants (Arizona ESS) and exposure to cancellations. The 2026 pivot to "essential capex only" + ESS redeployment is a rational correction, but it's correcting their own over-expansion. ROE/ROIC is currently negative; trend n/a precisely.
• Red flags (governance): chaebol structure → related-party dynamics with LG Chem (LGES buys CAM from LG Chem — a related-party supply relationship that helps cost security but warrants scrutiny on transfer pricing). No promotional-CEO behavior evident. No personal-enrichment red flags surfaced.

Net: competent operators dealt a bad hand who arguably over-extended at the top of the policy cycle; now executing a credible but defensive turn. Not a reason to own the stock; not a reason to short it either.

Lens 10 · Forensic Red Flags

financials.csv/filings/ empty → no statement-level forensics possible. Korean K-IFRS reporting (not US GAAP), with less granular English disclosure. Flags from public data:

1. AMPC accounting is the #1 forensic issue. From 2026, LGES books AMPC in revenue, not below the line. That inflates the top line and the optics of "revenue growth" (the "fifth consecutive quarter of growth" partly is the subsidy). The honest metric is ex-AMPC operating profit, which was −KRW 397.5B in Q1 2026. Any model that takes reported revenue/OP at face value overstates the franchise. Watch for: AMPC as a rising % of revenue and OP — the higher it goes, the more the "earnings" are a government transfer, and the bigger the cliff if it's repealed.
2. Stranded-asset / impairment risk. Two cancelled contracts + paused Arizona ESS line → the carrying value of purpose-built EV capacity is at risk. Watch for goodwill/PP&E impairment charges and onerous-contract provisions in 2026 filings. None confirmed yet; this is a forward flag.
3. Receivables/contract-asset risk post-cancellation — termination settlements, penalty recoveries vs. write-offs. Whether LGES recovers anything from Ford/FBPS for stranded capex is n/a (no litigation filed; clean policy-based termination per coverage).
4. Capex vs. cash flow divergence — the company outspent operating cash for years on the buildout (rising net debt); the 40% capex cut is partly a financing-necessity move, not only strategy.
5. Revenue recognition on long-term off-takes — standard percentage/volume recognition; the cancellations show booked backlog ≠ guaranteed revenue.

Regulatory findings (required sub-section):

• SEC (EDGAR LR/AAER): regulatory/regulatory-findings.md (generated 2026-06-17) confirms LGES has no CIK and is not an SEC filer — zero EDGAR enforcement findings, and none possible. (This is the one local file with content; it is a procedural note, not financial data.)
• Non-SEC enforcement / litigation ``:
• GM Chevy Bolt recall (2021-22): LG agreed to reimburse GM up to $1.9B; NHTSA opened an investigation into LGES batteries in 2022. The largest historical liability event — resolved financially, but a permanent reminder of cell-quality tail risk.
• Ford / FBPS contract terminations (Dec 2025): treated by all coverage as clean policy-driven terminations, NOT litigation — "a contract cancellation dispute rather than a lawsuit settlement… no evidence of ongoing litigation or arbitration at this time". Whether LGES pursues termination-fee claims later is open.
• Michigan environmental: unrelated class-action / chemical-spill chatter around an "LG" Holland, Michigan site appears in legal-news aggregators — attribution to LGES specifically is unconfirmed and likely conflates LG entities; flag as unverified, do not rely.
• Net: No material securities enforcement (not an SEC filer). The real legal/quality history is the $1.9B GM Bolt recall + NHTSA probe; the Dec-2025 cancellations are commercial, not legal — so far. "Verified via SEC EDGAR EFTS (no CIK → none), web search, and public coverage as of 2026-06-18."

---

Phase D — Project & stress-test

Lens 11 · Forward Projection

Caveat: web-only, no financials.csv to build bottom-up from clean actuals; loss-making with a government subsidy as the swing variable. EPS precision here is low-confidence ``. Fiscal year = calendar year (Dec). I project directionally rather than pretend to a point EPS.

Anchors ``: FY2025 revenue KRW 23.7T, OP KRW 1.3T (incl. AMPC); Q1 2026 revenue KRW 6.6T, OP −KRW 207.8B (incl. KRW 189.8B AMPC; ex-AMPC −KRW 397.5B). Shares outstanding ~234M (general; verify). TTM EPS ≈ −KRW 6,851.

• Bear (FY2026): EV demand stays weak, cancellations bite into 2027+ but 2026 utilization sags now; ESS ramps slower than hoped; AMPC roughly flat. Full-year operating result near breakeven-to-loss even with AMPC; deeply loss-making ex-AMPC. EPS modestly negative. ``.
• Base (FY2026): ESS NA capacity hits >50 GWh by year-end and starts contributing; capex down 40% preserves cash; AMPC ~KRW 0.9-1.1T for the year. Reported OP slightly positive (KRW 0.5-1.0T range), driven by AMPC; ex-AMPC still a loss. EPS roughly breakeven-to-slightly-positive on a reported basis. ``.
• Bull (FY2027+): ESS becomes a real profit center (data-center/grid demand structural), 46-series cylindrical ramps at Arizona with BMW/Tesla/Mercedes volume, LFP NA capacity lets LGES win IRA-eligible storage at scale, and the ex-AMPC business returns to profit as utilization normalizes. This is the only path to a clean earnings story — and it's a 2027-2028 event, not 2026.

The honest forecast is binary on two variables, not an EPS line:

1. Does AMPC survive? If the IRA's §45X AMPC is repealed/curtailed, LGES's only source of profit vanishes and the stock re-rates down hard. If it survives, the subsidy bridges the trough.
2. Can ESS replace the lost auto cells at a real margin? ~140 GWh NA ESS backlog says maybe — but at what gross margin vs. the stranded EV capacity it's backfilling?

Brier forecast (logged conceptually; not committing in breadth loop): "373220.KS reports a positive FY2026 operating profit (reported, AMPC-included)" — p ≈ 0.55 (AMPC + ESS likely just keep reported OP positive; high variance). And the one that actually matters: "373220.KS reports a positive FY2026 operating profit EXCLUDING AMPC" — p ≈ 0.15. Per --watchlist rules, no forecast.ts create run — breadth mode, dossier only.

Lens 12 · Bull vs Bear

Bull case. LGES is the West's default non-Chinese battery champion at the exact moment governments and OEMs are forced to de-risk from China. The EV air-pocket is cyclical, not terminal — global electrification still grinds forward, and when it re-accelerates LGES has the qualified capacity, the 46-series cylindrical wins (Tesla, BMW, Mercedes, Rivian), and a real solid-state roadmap. Meanwhile the ESS pivot is the genuine surprise: grid-scale + data-center storage demand is exploding, LGES locked ~140 GWh of NA backlog, is building dedicated LFP capacity, and ESS is less exposed to the consumer-EV demand cycle. Capex discipline (−40%) plus AMPC bridges the trough. If ESS scales and EV recovers into 2027-2028, today's loss-making trough is the buying point and the stock re-rates off P/B back toward a real earnings multiple.

Bear case. Three things can permanently impair the thesis: (1) Subsidy dependence — AMPC is the entire profit; ex-AMPC the company lost KRW ~400B in one quarter. A Trump-era IRA rollback isn't a haircut, it's removal of the only earnings. (2) The Chinese steamroller — CATL (40%+) and BYD own LFP, own the cost curve, are gaining share while the Korean trio bleeds it (−3.5pts YoY); LGES may be structurally the high-cost producer of a commodity. (3) Customer flight — Ford walked on 28.5% of revenue; FBPS walked; the "backlog" is revocable. Expectations baked into the price: at ~5.5x book with negative earnings, the market is already pricing an ESS-led recovery — so the upside is partly spent, while the downside (AMPC repeal + more cancellations + impairments) is not.

Pre-mortem (18 months out, thesis broke): It's late 2027. The IRA's §45X was curtailed in a 2026 budget fight; LGES's reported profit evaporated alongside the subsidy. EV demand stayed soft; another OEM trimmed a program. ESS grew but at thin margins, not enough to offset stranded EV lines, and LGES took multi-trillion-won impairments on Arizona/Michigan capacity. CATL localized into Europe/US via licensing and undercut on LFP. The stock is well below KRW 300K. The single thing that broke it: the profit was always a government transfer, and the government changed its mind.

Are multiples too high? On current economics, yes — you can't justify ~5.5x book and ~4.7x sales for a loss-making (ex-subsidy) commodity manufacturer losing share. The valuation is an option on ESS + recovery + subsidy-survival. That option has real value but it is not cheap.

Contrarian view (what the market refuses to see): The bullish consensus treats AMPC as a kicker and ESS as pure upside. The contrarian read is darker and more interesting: LGES may be quietly becoming an "ESS company that used to make EV batteries" — and if the data-center storage boom is as big as the AI-power thesis implies, a successful, less-cyclical, China-hedged grid-storage franchise could ultimately be worth more than the EV-cell business it's replacing. The market is mispricing this as a broken EV play when the real question is the quality and margin of the storage business being born. Both the bear (subsidy cliff) and this contrarian bull (ESS re-rating) are underpriced relative to the lazy "EV slowdown" narrative.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case:

• Structural break in how it makes money: the P&L is subsidy-dependent — KRW 189.8B AMPC turned a −KRW 397.5B core loss into a −KRW 207.8B reported loss. Short the subsidy, short the stock. A single line in a U.S. budget bill is the kill switch.
• Revenue concentration: Ford was ~28.5% of revenue and it vanished on a notice. That's not concentration risk in theory — it's concentration risk that already detonated. Who's next — does GM trim Ultium volumes if EV demand stays weak?
• Moat weaker than bulls think: "non-Chinese champion" is a policy moat. Policies change (they're changing). On pure cost/technology, CATL and BYD are ahead on LFP and gaining share — LGES is plausibly the high-cost producer of a commoditizing good, the worst structural position in manufacturing.
• Most dangerous competitor bulls underestimate: CATL, via licensing/localization (the Ford LRS model). If CATL can put its cost-leading LFP into US/EU plants under license while staying IRA-workable, LGES's eligibility moat collapses and it's left competing on cost it can't win.
• Worst capital allocation: the 2022-2024 build-everywhere capex spree — financed with debt — into a demand air-pocket. Now paying for it with paused plants and impairment risk. Related-party CAM sourcing from LG Chem (81.8% parent) is a governance asterisk.
• What must hold for today's price: AMPC survives intact and ESS scales at real margin and EV demand troughs in 2026 and recovers and no more cancellations and no impairments. That's a lot of "ands."
• Growth disappoints 20-30%: with no current earnings to cushion, a further demand/ESS shortfall pushes the ex-AMPC loss wider and forces impairments — the stock has meaningful downside below KRW 300K toward / below the IPO price.
• The single scenario that permanently impairs: §45X AMPC repeal + a second major OEM cancellation in the same year. Plausibility: not the base case, but with a hostile U.S. policy turn and a fragile EV demand backdrop, clearly more than a tail — call it a real 20-30% scenario over 18 months.

Lens 14 · Management Questions (ordered by information value)

1. If §45X AMPC is repealed or curtailed in a U.S. budget action, what is the ex-AMPC path to operating breakeven, and by when?
2. What was the FY2025 and Q1-2026 gross margin and operating margin EXCLUDING AMPC, by segment (EV vs ESS)?
3. What is the expected gross margin on the North American ESS backlog (~140 GWh) versus the EV-cell business it is backfilling?
4. After Ford and FBPS, what % of the stated order backlog is firm/non-cancellable vs. revocable on policy or demand grounds, and what are the termination-fee terms?
5. Do you expect impairment charges or onerous-contract provisions in 2026 on stranded EV capacity (Arizona ESS pause, cancelled-program lines)? Quantify the at-risk carrying value.
6. Will you pursue termination-fee / stranded-capex recovery from Ford and FBPS, and what is the realistic recoverable amount?
7. On unit cost, where do you sit versus CATL and BYD on LFP $/kWh, and what is the credible path to closing that gap?
8. How do you defend the non-Chinese eligibility moat if CATL/BYD localize via licensing (the Ford LRS model) inside IRA-compliant structures?
9. What utilization rate are your North American EV plants running at today, and what's the breakeven utilization?
10. What is the 2026 and 2027 capex plan in absolute KRW, the funding mix, and the net-debt trajectory through the trough?
11. On all-solid-state: what milestones gate the 2026 polymer and 2030 sulfide targets, and what is the realistic first-revenue date and addressable market?
12. How concentrated is remaining revenue in GM/Ultium, and what contractual protection exists against a volume cut there?
13. For ESS, how much demand is data-center/AI-driven, how durable is it, and how are you positioned versus Tesla Megapack and Chinese ESS suppliers?
14. What is the long-run target segment mix (EV vs ESS vs IT) by 2028-2030, and at what blended margin?
15. Given LG Chem's ~82% ownership, how do you ensure related-party CAM pricing is arm's-length, and what is governance/capital-return policy for minority holders?

---